AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Chiun Hsu

Chiun Hsu

National Taiwan University - Taipei / Taiwan
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 300472
國立台灣大學
person_outline Chiun Hsu's MOST POPULAR ARTICLES
1-) Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial The Lancet 389 (10088), 2492-2502, 2017
2-) Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial JAMA oncology 6 (11), e204564-e204564, 2020
3-) Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis Bmj 363, 2018
4-) Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma Journal of hepatology 72 (2), 307-319, 2020
5-) Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1–positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study Journal of Clinical Oncology 35 (36), 4050-4056, 2017